Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
02/05/2004 | CA2494358A1 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
02/05/2004 | CA2494233A1 Formulations and dosage forms for controlled delivery of topiramate |
02/05/2004 | CA2494098A1 Methods of using non-human animal apoliprotein a-i protein |
02/05/2004 | CA2494069A1 Pellicle-resistant gelatin capsule |
02/05/2004 | CA2493980A1 Gelatin capsule exhibiting reduced cross-linking |
02/05/2004 | CA2493878A1 Parenteral formulations containing a rapamycin hydroxyester |
02/05/2004 | CA2493761A1 Compositions comprising hmg-coa reductase inhibitor |
02/05/2004 | CA2493638A1 New mutant strains of pseudomonas fluorescens and variants thereof, methods for their production, and uses thereof in alginate production |
02/05/2004 | CA2493590A1 Auto-stimulating cells and method for making and using the same |
02/05/2004 | CA2493179A1 Sustained-release tablet composition comprising a dopamine receptor agonist |
02/05/2004 | CA2493076A1 Composition comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent |
02/05/2004 | CA2492490A1 Chinese herbal medical composition in the form of jelly |
02/05/2004 | CA2492424A1 Sustained-release tablet comprising reboxetine |
02/05/2004 | CA2491078A1 Percutaneous and perungual delivery system |
02/05/2004 | CA2490495A1 Method for the synthesis of anthracycline-peptide conjugates |
02/05/2004 | CA2488860A1 Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former |
02/04/2004 | EP1386935A1 Dual stimuli-responsive hydrogels and their synthetic methods |
02/04/2004 | EP1386934A1 Diagnostic agents for pancreatic exocrine function |
02/04/2004 | EP1386927A1 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors |
02/04/2004 | EP1386905A1 Stable solution of reduced coenzyme q |
02/04/2004 | EP1386614A1 Herbal pharmaceutical composition for treatment of hiv/aids patients |
02/04/2004 | EP1386613A1 Compositions for preparing external carbon dioxide agents |
02/04/2004 | EP1386606A1 Stable high− concentration injection containing pyrazolone derivative |
02/04/2004 | EP1386605A1 Improved transdermal delivery system for the administration of rotigotine |
02/04/2004 | EP1386604A1 Improved transdermal delivery system |
02/04/2004 | EP1386600A1 Composition gelled with a dextrin ester |
02/04/2004 | EP1385988A2 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications |
02/04/2004 | EP1385959A2 Method of producing recombinant antibodies against tumours |
02/04/2004 | EP1385948A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
02/04/2004 | EP1385888A1 Method for producing low-viscous, aqueous cellulose ether solutions |
02/04/2004 | EP1385857A1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
02/04/2004 | EP1385554A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
02/04/2004 | EP1385553A1 Soluble protein-polymer systems for drug delivery |
02/04/2004 | EP1385552A1 Oral delivery method and composition for solid medications or dietary supplements |
02/04/2004 | EP1385538A2 Chimeric vaccines |
02/04/2004 | EP1385530A1 Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption |
02/04/2004 | EP1385528A2 Disinfecting and solubilizing steroid compositions |
02/04/2004 | EP1385525A2 Targeted oxidative therapeutic formulation |
02/04/2004 | EP1385521A2 Pharmaceutical composition containing pde v inhibitors and surfactants |
02/04/2004 | EP1385519A2 Compounds for treating inflammatory diseases |
02/04/2004 | EP1385511A1 Composition comprising antifungal agents for treating vulvovaginitis and vaginosis |
02/04/2004 | EP1385502A2 Method for the production of anhydrous, pharmaceutical formulations of xanthogenates |
02/04/2004 | EP1385494A2 Aerosol compositions containing formoterol and a steroid such as e.g. budesonide or fluticasone for delivery into the lungs |
02/04/2004 | EP1385490A1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
02/04/2004 | EP1385489A1 Coated granules based on angiotensin-converting enzyme inhibitor |
02/04/2004 | EP1385486A1 A novel coating for a sustained release pharmaceutical composition |
02/04/2004 | EP1385485A1 Bioerodible poly(orthoesters) from dioxolane-based diketene acetals |
02/04/2004 | EP1385484A2 Compositions and methods of manufacture for oral dissolvable dosage forms |
02/04/2004 | EP1385482A1 An effervescent solid composition of matter |
02/04/2004 | EP1385480A1 Liposomes |
02/04/2004 | EP1385479A1 Liposome composition for improved intracellular delivery of a therapeutic agent |
02/04/2004 | EP1385475A2 Immunity adjuvant containing a complexed metal cation and vaccine containing same |
02/04/2004 | EP1385459A2 Transdermal delivery of pergolide |
02/04/2004 | EP1385452A1 Ophthalmic drug delivery device |
02/04/2004 | EP1257304B1 Foam-forming wound dressing |
02/04/2004 | EP1228147B1 Dye labeled imidazoquinoline compounds |
02/04/2004 | EP1216041B1 High lipid diet |
02/04/2004 | EP1141124B1 Anionic-cationic polyion complexes comprising zwitterionic monomer component |
02/04/2004 | EP1035859B1 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |
02/04/2004 | EP1024784A4 Beta-d glucan topical composition |
02/04/2004 | EP1014926B1 Therapeutic and cosmetic compositions, their use and method for the preparation thereof |
02/04/2004 | EP0988324B1 Method for manufacturing pure guar meal |
02/04/2004 | EP0983264B1 Method of manufacturing sertindole |
02/04/2004 | EP0906069B1 Tissue re-surfacing with hydrogel-cell compositions |
02/04/2004 | EP0730404B1 Amphiphilic imidazolinium derivatives |
02/04/2004 | EP0642507B1 Transition state analogues of cocaine, their use for producing catalytic antibodies against cocaine and use of the same in diagnosis and therapy |
02/04/2004 | EP0576521B2 Improvements in or relating to contrast agents |
02/04/2004 | CN1473054A Cellulosic particle for pharmaceutical preparation |
02/04/2004 | CN1473047A Method for treating hypogonadism |
02/04/2004 | CN1473044A Inhalative solution formulation containing tiotropium salt |
02/04/2004 | CN1473038A Inhalative solution formulation containing tiotropium salt |
02/04/2004 | CN1473036A Tablets quickly disintegrating in oral cavity and process for producing same |
02/04/2004 | CN1473035A Compositions containing substained-release fine grains for tablets quickly disintegrable in oral cavity and process for producing same |
02/04/2004 | CN1471981A Surface treatment for SARS lungs bacteria infection |
02/04/2004 | CN1471976A Babu agent matrix and its preparing method |
02/04/2004 | CN1471972A Fibrin ferment hemostatic suppository |
02/04/2004 | CN1471953A Medicinal plant composition for treating AIDS patient |
02/04/2004 | CN1471911A Oral film agent of vanadium biguanide complex for diabetes and its use |
02/04/2004 | CN1471907A Particle for releasing polymer coating |
02/04/2004 | CN1137136C Targeted cytotoxic anthracycline analogs |
02/04/2004 | CN1136918C Vaccines |
02/04/2004 | CN1136853C Tablets containing 'beta'-lactam antibiotic and process for producing the same |
02/04/2004 | CN1136852C Pharmaceutical formulations of cefaclor |
02/04/2004 | CN1136846C Formaldehyde injection for treating infective disease of animal |
02/04/2004 | CN1136843C Transdermal therapeutic system containing estradiol |
02/04/2004 | CN1136842C Drug composition with controlled drug release rate |
02/04/2004 | CN1136838C Solid, quick dissolving cetirizine fomulation |
02/04/2004 | CN1136791C Use of Solubilized carotenoid prepn. for colouring foods and pharmaceutical prepn. |
02/03/2004 | US6686442 Peptide nucleic acid for use in veterinary medicine |
02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
02/03/2004 | US6686342 Bicompatible poly-β-1→4-N-acetylglucosamine |
02/03/2004 | US6686330 Low-foaming; good biodegradability; can be used in polymer, antifoaming, biocidal, coating, fertilizer, pharmaceutical, and drilling fluid compositions. |
02/03/2004 | US6686179 Polypeptide for use in the treatment of thrombosis, cancer, inflammation, autoimmune, and bone disorders |
02/03/2004 | US6686175 IP-10/MIG receptor designated CXCR3, nucleic acids, and methods of use therefor |
02/03/2004 | US6685971 Oil homogenized with sterols; protective coating for stomach |
02/03/2004 | US6685970 Compositions containing proanthocyanidin and a vitamin B6 derivative or a salt thereof |
02/03/2004 | US6685969 Treatment for ectoparasites |
02/03/2004 | US6685967 Spray dried powder |
02/03/2004 | US6685965 Process for stabilizing levogyre ascorbic acid (laa), a stable aqueous laa composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment |
02/03/2004 | US6685964 Coated crystals |